High-mobility group box 1 at the time of parturition in women with gestational diabetes mellitus

Ashley V. Hill, Ramkumar Menon, Maria Perez-Patron, Genny Carrillo, Xiaohui Xu, Brandie D. Taylor

Research output: Contribution to journalArticle

Abstract

Problem: High-mobility group box 1 (HMGB1), a danger-associated molecular pattern marker, may indicate sterile inflammation through innate immune pathways. HMGB1 is implicated in hyperglycemia and excess glucose in trophoblast. Metabolic dysfunction and dyslipidemia are associated with gestational diabetes mellitus (GDM), but few studies examined associations between HMGB1 and GDM. We determined HMGB1 levels, and the ratio of HMGB1 to innate immune markers, in women with GDM at parturition. Method of study: This case-control study of 50 GDM pregnancies and 100 healthy controls utilized data and plasma samples from PeriBank. HMGB1, pentraxin-3, and interleukin (IL)-6 were measured by ELISA. Logistic regression calculated odds ratios (OR) and 95% confidence intervals (CI) adjusting for age, pre-pregnancy body mass index, and type of labor. Results: There were no significant associations between HMGB1 and GDM. The ratio of HMGB1 to pentraxin-3 and IL-6 did not alter the odds of GDM. There was a significant statistical interaction between HMGB1 and maternal age (P =.02). When associations were examined by age groups, HMGB1 was associated with reduced odds of HMGB1 among women ≤25 (AOR = 0.007 CI 95% <0.001-0.3). Odds ratios increased as age increased (AOR range 1.2-3.8) but results were not statistically significant. Conclusion: High-mobility group box 1 was not associated with GDM. However, we found evidence that maternal age was a potential effect modifier of the relationship between HMGB1 and GDM. As there is growing evidence that HMGB1 may play important roles in reproduction, future studies should explore maternal factors that may alter HMGB1 levels.

Original languageEnglish (US)
Article numbere13175
JournalAmerican Journal of Reproductive Immunology
DOIs
StateAccepted/In press - Jan 1 2019

Fingerprint

Gestational Diabetes
Parturition
Maternal Age
Interleukin-6
Odds Ratio
Confidence Intervals
Pregnancy
Trophoblasts
Dyslipidemias
Hyperglycemia
Reproduction
Case-Control Studies
Body Mass Index
Age Groups
Biomarkers
Logistic Models
Enzyme-Linked Immunosorbent Assay
Mothers
Inflammation
Glucose

Keywords

  • gestational diabetes mellitus
  • high-mobility group box 1
  • innate immunity
  • pregnancy

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology
  • Reproductive Medicine
  • Obstetrics and Gynecology

Cite this

High-mobility group box 1 at the time of parturition in women with gestational diabetes mellitus. / Hill, Ashley V.; Menon, Ramkumar; Perez-Patron, Maria; Carrillo, Genny; Xu, Xiaohui; Taylor, Brandie D.

In: American Journal of Reproductive Immunology, 01.01.2019.

Research output: Contribution to journalArticle

Hill, Ashley V. ; Menon, Ramkumar ; Perez-Patron, Maria ; Carrillo, Genny ; Xu, Xiaohui ; Taylor, Brandie D. / High-mobility group box 1 at the time of parturition in women with gestational diabetes mellitus. In: American Journal of Reproductive Immunology. 2019.
@article{0d43444dcea943c189bbe9b164aae4c4,
title = "High-mobility group box 1 at the time of parturition in women with gestational diabetes mellitus",
abstract = "Problem: High-mobility group box 1 (HMGB1), a danger-associated molecular pattern marker, may indicate sterile inflammation through innate immune pathways. HMGB1 is implicated in hyperglycemia and excess glucose in trophoblast. Metabolic dysfunction and dyslipidemia are associated with gestational diabetes mellitus (GDM), but few studies examined associations between HMGB1 and GDM. We determined HMGB1 levels, and the ratio of HMGB1 to innate immune markers, in women with GDM at parturition. Method of study: This case-control study of 50 GDM pregnancies and 100 healthy controls utilized data and plasma samples from PeriBank. HMGB1, pentraxin-3, and interleukin (IL)-6 were measured by ELISA. Logistic regression calculated odds ratios (OR) and 95{\%} confidence intervals (CI) adjusting for age, pre-pregnancy body mass index, and type of labor. Results: There were no significant associations between HMGB1 and GDM. The ratio of HMGB1 to pentraxin-3 and IL-6 did not alter the odds of GDM. There was a significant statistical interaction between HMGB1 and maternal age (P =.02). When associations were examined by age groups, HMGB1 was associated with reduced odds of HMGB1 among women ≤25 (AOR = 0.007 CI 95{\%} <0.001-0.3). Odds ratios increased as age increased (AOR range 1.2-3.8) but results were not statistically significant. Conclusion: High-mobility group box 1 was not associated with GDM. However, we found evidence that maternal age was a potential effect modifier of the relationship between HMGB1 and GDM. As there is growing evidence that HMGB1 may play important roles in reproduction, future studies should explore maternal factors that may alter HMGB1 levels.",
keywords = "gestational diabetes mellitus, high-mobility group box 1, innate immunity, pregnancy",
author = "Hill, {Ashley V.} and Ramkumar Menon and Maria Perez-Patron and Genny Carrillo and Xiaohui Xu and Taylor, {Brandie D.}",
year = "2019",
month = "1",
day = "1",
doi = "10.1111/aji.13175",
language = "English (US)",
journal = "American Journal of Reproductive Immunology and Microbiology",
issn = "1046-7408",
publisher = "Wiley-Blackwell",

}

TY - JOUR

T1 - High-mobility group box 1 at the time of parturition in women with gestational diabetes mellitus

AU - Hill, Ashley V.

AU - Menon, Ramkumar

AU - Perez-Patron, Maria

AU - Carrillo, Genny

AU - Xu, Xiaohui

AU - Taylor, Brandie D.

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Problem: High-mobility group box 1 (HMGB1), a danger-associated molecular pattern marker, may indicate sterile inflammation through innate immune pathways. HMGB1 is implicated in hyperglycemia and excess glucose in trophoblast. Metabolic dysfunction and dyslipidemia are associated with gestational diabetes mellitus (GDM), but few studies examined associations between HMGB1 and GDM. We determined HMGB1 levels, and the ratio of HMGB1 to innate immune markers, in women with GDM at parturition. Method of study: This case-control study of 50 GDM pregnancies and 100 healthy controls utilized data and plasma samples from PeriBank. HMGB1, pentraxin-3, and interleukin (IL)-6 were measured by ELISA. Logistic regression calculated odds ratios (OR) and 95% confidence intervals (CI) adjusting for age, pre-pregnancy body mass index, and type of labor. Results: There were no significant associations between HMGB1 and GDM. The ratio of HMGB1 to pentraxin-3 and IL-6 did not alter the odds of GDM. There was a significant statistical interaction between HMGB1 and maternal age (P =.02). When associations were examined by age groups, HMGB1 was associated with reduced odds of HMGB1 among women ≤25 (AOR = 0.007 CI 95% <0.001-0.3). Odds ratios increased as age increased (AOR range 1.2-3.8) but results were not statistically significant. Conclusion: High-mobility group box 1 was not associated with GDM. However, we found evidence that maternal age was a potential effect modifier of the relationship between HMGB1 and GDM. As there is growing evidence that HMGB1 may play important roles in reproduction, future studies should explore maternal factors that may alter HMGB1 levels.

AB - Problem: High-mobility group box 1 (HMGB1), a danger-associated molecular pattern marker, may indicate sterile inflammation through innate immune pathways. HMGB1 is implicated in hyperglycemia and excess glucose in trophoblast. Metabolic dysfunction and dyslipidemia are associated with gestational diabetes mellitus (GDM), but few studies examined associations between HMGB1 and GDM. We determined HMGB1 levels, and the ratio of HMGB1 to innate immune markers, in women with GDM at parturition. Method of study: This case-control study of 50 GDM pregnancies and 100 healthy controls utilized data and plasma samples from PeriBank. HMGB1, pentraxin-3, and interleukin (IL)-6 were measured by ELISA. Logistic regression calculated odds ratios (OR) and 95% confidence intervals (CI) adjusting for age, pre-pregnancy body mass index, and type of labor. Results: There were no significant associations between HMGB1 and GDM. The ratio of HMGB1 to pentraxin-3 and IL-6 did not alter the odds of GDM. There was a significant statistical interaction between HMGB1 and maternal age (P =.02). When associations were examined by age groups, HMGB1 was associated with reduced odds of HMGB1 among women ≤25 (AOR = 0.007 CI 95% <0.001-0.3). Odds ratios increased as age increased (AOR range 1.2-3.8) but results were not statistically significant. Conclusion: High-mobility group box 1 was not associated with GDM. However, we found evidence that maternal age was a potential effect modifier of the relationship between HMGB1 and GDM. As there is growing evidence that HMGB1 may play important roles in reproduction, future studies should explore maternal factors that may alter HMGB1 levels.

KW - gestational diabetes mellitus

KW - high-mobility group box 1

KW - innate immunity

KW - pregnancy

UR - http://www.scopus.com/inward/record.url?scp=85070777602&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85070777602&partnerID=8YFLogxK

U2 - 10.1111/aji.13175

DO - 10.1111/aji.13175

M3 - Article

C2 - 31353785

AN - SCOPUS:85070777602

JO - American Journal of Reproductive Immunology and Microbiology

JF - American Journal of Reproductive Immunology and Microbiology

SN - 1046-7408

M1 - e13175

ER -